Dr. Zhou is the founder and CEO of Centrillion Biosciences, a leading genomic technology and service company in the Silicon Valley. He is also a senior advisor to Covington and Burling LLP, a top international law firm well known for its life sciences, regulatory and government relationship practices. Prior to founding Centrillion, he was a partner at the technology law firm Wilson Sonsini Goodrich & Rosati, where he advised technology start-ups. At Affymetrix (NASDAQ: AFFX) which pioneered the entire high throughput DNA analysis industry, he served as a senior vice president of intellectual property and advanced technology, responsible for intellectual property and technology management. He was also the founding China country manager and credited for building Affymetrix’ rapid growing China business and for establishing a number of translational medicine and biochip service centers in collaboration with the Chinese government. He was instrumental in establishing the first US-China joint technology biochip R&D program, which resulted in the commercialization of world’s first personal genechip system.

Additionally, Dr. Zhou was a partner at Jedi Venture partners and served as a director and advisory to start-up companies in digital media and life sciences industry. He is currently serving as the president and board member of Hua Yuan Science and Technology association (HYSTA), which focuses on promoting technology entrepreneurship in the US and China.

Dr. Zhou received his Ph.D. form Virginia Tech, his postdoctoral training from Emory University Medical School and his J.D. from Stanford University Law School. He also graduated from the Harvard Business School General Manager program.